Apollo to Provide €1 Billion Capital Solution to Vonovia in Third Transaction
October 02, 2024 16:05 ET
|
Apollo Global Management, Inc.
NEW YORK, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Apollo (NYSE: APO) today announced that it has entered into an agreement for Apollo affiliates and other long term investors to provide c. €1 billion to...
Option Care Health to Announce Third Quarter 2024 Financial Results and Host Conference Call
October 02, 2024 16:05 ET
|
Option Care Health, Inc.
BANNOCKBURN, Ill., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion...
Processa Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of NGC-Cap in Metastatic Breast Cancer
October 02, 2024 16:05 ET
|
Processa Pharmaceuticals, Inc.
Phase 2 trial is an adaptive designed randomized study comparing NGC-Cap to monotherapy capecitabineResults from this Phase 2 trial will evaluate NGC-Cap’s safety-efficacy profile and help to define...
Venus Concept to Release Third Quarter of Fiscal Year 2024 Financial Results on November 13, 2024
October 02, 2024 16:05 ET
|
Venus Concept Inc.
TORONTO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that third quarter of...
Globus Maritime Limited Announces the Delivery of a 2024-Built Ultramax Dry Bulk Vessel “Glbs Magic,” Expanding Fleet to Eight Vessels
October 02, 2024 16:05 ET
|
Globus Maritime Limited
GLYFADA, Greece, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Globus Maritime Limited (the “Company” or "Globus") (NASDAQ: GLBS), a dry bulk shipping company, announced today that it took delivery of the M/V...
Parsons Awarded Position on $4B Defense Threat Reduction Agency Contract
October 02, 2024 16:05 ET
|
Parsons Services Company
CHANTILLY, Va., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that the company was awarded a position on an indefinite-delivery, indefinite-quantity (IDIQ)...
Range Impact Announces Sale of Cannabinoid Drug Development Business
October 02, 2024 16:05 ET
|
Range Impact, Inc.
CLEVELAND, OHIO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) (“Range Impact” or the “Company”), a public company dedicated to improving the health and wellness of people and the...
Kineta Announces the Extension of the TuHURA Biosciences Exclusivity and Right of First Offer Agreement for KVA12123, Kineta’s VISTA blocking antibody Currently in Phase 1
October 02, 2024 16:05 ET
|
Kineta, Inc.
TuHURA has extended their exclusivity and right of first offer pursuant to the terms of the agreement. Kineta and TuHURA are collaborating on the ongoing Phase 1/Phase 2 clinical trial in patients...
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
October 02, 2024 16:05 ET
|
Verve Therapeutics
BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on September 30,...
Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028
October 02, 2024 16:05 ET
|
Integer Holdings Corporation
PLANO, Texas, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading medical device contract development and manufacturing organization,...